BR9708161A - Peptídeos com aumentada afinidade de ligação para moléculas hla - Google Patents

Peptídeos com aumentada afinidade de ligação para moléculas hla

Info

Publication number
BR9708161A
BR9708161A BR9708161A BR9708161A BR9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A
Authority
BR
Brazil
Prior art keywords
peptides
binding affinity
increased binding
hla molecules
hla
Prior art date
Application number
BR9708161A
Other languages
English (en)
Inventor
Alessandro Sette
Robert W Chestnut
John Sidney
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Publication of BR9708161A publication Critical patent/BR9708161A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9708161A 1996-03-11 1997-03-10 Peptídeos com aumentada afinidade de ligação para moléculas hla BR9708161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1311396P 1996-03-11 1996-03-11
PCT/US1997/003778 WO1997033602A1 (en) 1996-03-11 1997-03-10 Peptides with increased binding affinity for hla molecules

Publications (1)

Publication Number Publication Date
BR9708161A true BR9708161A (pt) 1999-07-27

Family

ID=21758378

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708161A BR9708161A (pt) 1996-03-11 1997-03-10 Peptídeos com aumentada afinidade de ligação para moléculas hla

Country Status (9)

Country Link
EP (1) EP0914142B9 (pt)
JP (2) JP2001504799A (pt)
CN (1) CN1225590A (pt)
AT (1) ATE511849T1 (pt)
AU (1) AU2203797A (pt)
BR (1) BR9708161A (pt)
CA (1) CA2248657A1 (pt)
ES (1) ES2367640T3 (pt)
WO (1) WO1997033602A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
US6183746B1 (en) 1997-10-09 2001-02-06 Zycos Inc. Immunogenic peptides from the HPV E7 protein
EP1064022A4 (en) * 1998-03-13 2004-09-29 Epimmune Inc HLA BINDING PEPTIDES AND THEIR APPLICATIONS
WO2000044775A2 (en) * 1999-01-27 2000-08-03 Epimmune Inc. Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
CA2386341A1 (en) * 1999-11-18 2001-05-25 Epimmune Inc. Heteroclitic analogs and related methods
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
CA2415923C (en) 2000-07-12 2011-10-25 Agensys, Inc. Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
EP2022797A3 (en) 2000-08-28 2011-11-09 Agensys, Inc. Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
US7459539B2 (en) 2000-12-15 2008-12-02 Agensys, Inc. Antibody that binds zinc transporter protein 108P5H8
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
WO2002092842A2 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
WO2002094994A2 (en) 2001-05-18 2002-11-28 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
ES2532757T3 (es) 2001-09-06 2015-03-31 Agensys, Inc. Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
WO2003087126A2 (en) * 2002-04-05 2003-10-23 Epimmune Inc. Heteroclitic analogs and related methods
JP2005535627A (ja) * 2002-06-25 2005-11-24 シティ・オブ・ホープ アジュバント不含ペプチド・ワクチン
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
JP2006508163A (ja) 2002-11-27 2006-03-09 アジェンシス， インコーポレイテッド 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
AU2004210975B2 (en) 2003-02-10 2008-04-10 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
NZ572940A (en) 2003-05-30 2010-04-30 Agensys Inc Prostate stem cell antigen (PSCA) variants and subsequences thereof
WO2005118864A2 (en) 2004-05-28 2005-12-15 Agensys, Inc. Antibodies and related molecules that bind to psca proteins
RU2413735C2 (ru) 2005-03-31 2011-03-10 Эдженсис, Инк. Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
EP1982728A4 (en) * 2006-01-23 2009-11-11 Greenpeptide Co Ltd HEPATITIS C-VIRUS DERIVED PEPTIDE
US20090023895A1 (en) * 2006-02-07 2009-01-22 Nec Corporation Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide
US8324345B2 (en) 2006-10-12 2012-12-04 Nec Corporation HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
CN102066410B (zh) 2007-11-01 2017-01-18 梅约医学教育与研究基金会 Hla‑dr结合肽和它们的应用
WO2010086294A2 (en) 2009-01-28 2010-08-05 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
SG10201604236RA (en) * 2011-05-26 2016-07-28 Geneius Biotechnology Investments Llc Modulated Immunodominance Therapy
CN110651189A (zh) 2017-03-03 2020-01-03 特雷斯生物公司 肽疫苗
MA53543A (fr) 2018-09-04 2021-07-14 Treos Bio Ltd Vaccins peptidiques
US11161892B1 (en) 2020-12-07 2021-11-02 Think Therapeutics, Inc. Method of compact peptide vaccines using residue optimization
US11421015B2 (en) 2020-12-07 2022-08-23 Think Therapeutics, Inc. Method of compact peptide vaccines using residue optimization
US11058751B1 (en) 2020-11-20 2021-07-13 Think Therapeutics, Inc. Compositions for optimized RAS peptide vaccines
US11464842B1 (en) 2021-04-28 2022-10-11 Think Therapeutics, Inc. Compositions and method for optimized peptide vaccines using residue optimization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200320A (en) * 1987-12-07 1993-04-06 National Jewish Center For Immunology And Respiratory Medicine Method for identifying useful polypeptide vaccines
CA2141960A1 (en) 1992-08-07 1994-02-17 Ralph T. Kubo Hla binding peptides and their uses
US20050271676A1 (en) * 1993-03-05 2005-12-08 Epimmune Inc. Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
CA2168583C (en) * 1993-08-02 2007-10-02 Francis V. Chisari Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
KR100235849B1 (ko) * 1993-10-19 1999-12-15 에가시라 구니오 HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS)

Also Published As

Publication number Publication date
JP2009108097A (ja) 2009-05-21
WO1997033602A1 (en) 1997-09-18
EP0914142B9 (en) 2012-01-04
CA2248657A1 (en) 1997-09-18
ATE511849T1 (de) 2011-06-15
CN1225590A (zh) 1999-08-11
EP0914142B1 (en) 2011-06-08
AU2203797A (en) 1997-10-01
ES2367640T3 (es) 2011-11-07
EP0914142A4 (en) 2004-06-23
JP2001504799A (ja) 2001-04-10
EP0914142A1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
BR9708161A (pt) Peptídeos com aumentada afinidade de ligação para moléculas hla
DE69711083D1 (de) Kontaktstift für prüfzwecke
DE69729829D1 (de) Zusammensetzung für Wasser-enthaltende Dispersion
WO1999015658A3 (en) Human regulatory molecules
DE69818157D1 (de) Instrument für Eingriffe am Uterus
DE69017300D1 (de) Nager mit geringem Verschleiss für chirurgischen Retraktor.
EA199800667A1 (ru) Новые фенантридины
ATE424560T1 (de) Marker für neuromyelitis optica
ATE346922T1 (de) Domäne 1 beta2-gpi polypetiden und deren diagnostische und therepeutische verwendungen
DE69005530D1 (de) Lüfteranordnung für Wechselstromfahrzeuggenerator.
DE69830255D1 (de) Testeinheit zur Prüfung von Steckverbindern
BR9804676A (pt) Processo para o teste de um dispositivo de embreagem automatizado.
DE19780486T1 (de) Druck-Zug-Ventilanordnung für einen Motorzylinder
DE69715430D1 (de) Hydrodynamische schmiermitteldichtung für niedrige drehmomente
DE69721506D1 (de) Betriebsverfahren für eine ionenfalle
DE69625833D1 (de) Testkarte für Analysen
ATE404208T1 (de) Uridin-therapie für patienten mit erhöhten purin- werten
DE59005619D1 (de) Rollenprüfstand zur kombinierten Leistungs- und Bremsenprüfung an Kraftfahrzeugen.
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
BR9808729A (pt) Processo para a preparação de um anti-oxidante
PT801179E (pt) Dispositivo para controlo da valvula de um autoclismo
DE59610901D1 (de) Gehäuse für eine elektrische Baugruppe
NO900052L (no) Fremgangsmaate for betjening av en oljebroenn til havs.
AR019572A1 (es) Procedimiento de adsorcion para la desaromatizacion de hidrocarburos.
FR2720515B1 (fr) Instrument spatial d'observation laser, et véhicule spatial le comportant.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , 7A , 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006.